Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 18, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, May 15, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jasper Hellweg Maintained (VRTX) at Strong Buy with Increased Target to $320 on, May 15th, 2020
Jasper Hellweg of Argus Research, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $270 to $320 on, May 15th, 2020.
Jasper has made no other calls on VRTX in the last 4 months.
There are 15 other peers that have a rating on VRTX. Out of the 15 peers that are also analyzing VRTX, 3 agree with Jasper's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Geoffrey Porges of "SVB Leerink" Maintained at Hold with Increased Target to $263 on, Thursday, April 30th, 2020
- Brian Abrahams of "RBC Capital" Downgraded from Buy to Hold and Increased Target to $260 on, Tuesday, April 28th, 2020
- Brian Skorney of "Baird" Downgraded from Buy to Hold and Increased Target to $230 on, Friday, January 31st, 2020
These are the ratings of the 12 analyists that currently disagree with Jasper
- Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $305 on, Friday, May 1st, 2020
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $295 on, Thursday, April 30th, 2020
- Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $283 on, Thursday, April 30th, 2020
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $305 on, Thursday, April 30th, 2020
- Kevin Huang of "CFRA" Maintained at Strong Buy with Increased Target to $297 on, Thursday, April 30th, 2020
- Liisa Bayko of "JMP Securities" Maintained at Buy with Increased Target to $285 on, Thursday, April 30th, 2020
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $277 on, Thursday, April 30th, 2020
- Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $285 on, Thursday, April 30th, 2020
- Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $298 on, Tuesday, April 21st, 2020
- Gena Wang of "Barclays" Initiated at Buy on, Friday, March 20th, 2020
- Alethia Young of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $275 on, Wednesday, March 11th, 2020
- Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $295 on, Friday, January 31st, 2020
